|
State of Florida
Department of Health, Bureau of Epidemiology
EPI UPDATE
April 21, 1999
Richard S. Hopkins, M.D., M.S.P.H., Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Natalie E. Tackett, Epi Update Editor
Bureau of Epidemiology Frequent Contributors:
Steven Wiersma, M.D., M.P.H., Deputy State Epidemiologist |
William J. Bigler, Ph.D., M.S. Senior Epidemiologist |
Jodi Baldy, M.P.H., Biological Scientist IV |
Ursula E. Bauer, Ph.D.,
Chronic Disease Epidemiologist |
John Werth, M.A.
Bureau Education Coordinator |
Lisa Conti, D.V.M., M.P.H., State Public Health Veterinarian |
| |
Regional
Epidemiologists |
Dolly
Katz, Ph.D., M.P.H.,
SE Florida |
Roger Sanderson, R.N., M.A.,
SW Florida |
Carina
Blackmore, M.S. Vet. Med., Ph.D., NE Florida |
Zuber Mulla, M.S.P.H.,
Central Florida |
Gérard
Krause, M.D., D.T.M.H.,
NW Florida |
Please print out this material and share with epidemiology staff, county
health department directors, administrators, medical directors, nursing directors,
environmental health directors and others with an interest in information of this type.
Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a
week for consultation at our main number ( 850/245-4401) PLEASE NOTE:
Consultation after 5 p.m. & on weekends is intended for emergencies.
Epi Update has a home on the World Wide Web at ---
http://www.doh.state.fl.us
The Florida Clean Indoor Air Act regulates smoking in indoor public
places.
To file a complaint call 1-800-337-3742
In this issue:
1. News Release Urges Caution in the Wake of Florida Wildfires
2. Surveillance of Morbidity During Wildfires
3. Surveillance of Morbidity during Wildfires: Lessons Learned in 1998 and
Tips for 1999
4. Epidemiology Grand Rounds for April
5. Hepatitis C Guidelines
6. Influenza Summary Report
7. Florida Past: Public Health Pioneers, Polio Vaccines and Prevention
Campaigns
8. Weekly Disease Table - Week 15
Wildfires once again threaten Floridas communities and natural environments. The
following Epi Update articles are intended to assist county health departments in
responding to the public health issues associated with such fires. The first article is a
news release prepared jointly by the Department of Health and the Department of
Environmental Protection. Following are two articles pertaining to the wildfires of 1998.
The MMWR article, authored by B. Sorensen, MD, Marie Fuss, RN, Zuber Mulla, MSPH and
others, re-caps surveillance and epidemiology issues related to last years fires in
central Florida. The third fire article offers further reflections about the surveillance
and epidemiologic activities implemented as part of the response to those fires.
1. News Release Urges Caution in Wake of Florida Wildfires
FOR IMMEDIATE RELEASE
April 21, 1999
CONTACT: Catherine A. Arnold
DEPARTMENTS OF HEALTH AND ENVIRONMENTAL PROTECTION
URGE CAUTION IN WAKE OF WILDFIRES
High levels of smoke and pollutants may cause health problems for some
TALLAHASSEEState health and environmental officials have issued an advisory as a
result of the recent wildfires. The forest fires are causing an increase in the air
pollution in the areas of the fires and surrounding areas. The pollution resulting from
the fires combined with emissions from cars and trucks, hot temperatures and low winds
push air quality into the unhealthy range for sensitive individuals. This degraded
air quality can adversely affect the respiratory system and may aggravate heart and lung
problems such as asthma and emphysema.
Persons in the areas affected by the fires with respiratory conditions or heart disease
should avoid physical exertion and outdoor activity. This caution also extends to young
children and the elderly.
Individuals who have respiratory conditions and do not have access to air conditioning
should consider spending time in areas such as shopping malls, public libraries or
museums.
If you feel you are experiencing adverse health affects, contact a physician for an
evaluation or advice. This cautionary advisory will remain in effect as long as the state
is suffering from wildfires and the weather conditions remain hot with low winds. Citizens
are urged to exercise caution in accordance with local area conditions.
2. Surveillance of Morbidity during Wildfires
Reprinted from the February 05, 1999 / 48(04);78-79 issue of the MMWR
Several large wildfires occurred in Florida during June-July 1998, many involving both
rural and urban areas in Brevard, Flagler, Orange, Putnam, Seminole, and Volusia counties
(1,2). By July 22, a total of 2277 fires had burned 499,477 acres throughout the state
(Florida Department of Community Affairs, unpublished data, 1998). On June 22, after
receiving numerous phone calls from persons complaining of respiratory problems
attributable to smoke, the Volusia County Health Department issued a public health alert
(2) advising persons with pre-existing pulmonary or cardiovascular conditions to avoid
outdoor air in the vicinity of the fires. To determine whether certain medical conditions
increased in frequency during the wildfires, the Volusia County Health Department and the
Florida Department of Health initiated surveillance of selected conditions. This report
summarizes the results of this investigation.
The surveillance system monitored the frequency of patient visits associated with
selected conditions at seven hospitals in Volusia County and one hospital in Flagler
County. The medical records departments of these eight hospitals furnished data about
persons seen in the emergency departments (EDs) and/or admitted for the selected
conditions during June 1-July 6, 1998. For comparison, the hospitals also provided the
same information for June 1-July 6, 1997. Data from the eight hospitals were combined for
analysis.
From 1997 to 1998, ED visits increased substantially for asthma (91%), bronchitis with
acute exacerbation (132%), and chest pain (37%). ED visits for painful respiration
decreased (27%). Changes in the number of admissions were minimal.
Reported by: B Sorensen, MD, M Fuss, Volusia County Health Dept; Z Mulla, MSPH, W
Bigler, PhD, S Wiersma, MD, R Hopkins, MD, State Epidemiologist, Florida Dept of Health.
Editorial Note
Editorial Note: In response to the wildfires in Florida, infection-control
practitioners and public relations professionals at these local hospitals were used as
liaisons between the medical records staff at their respective hospitals and the health
department. The data were used to quantify the extent of morbidity possibly related to the
wildfires.
The findings in this report are subject to at least two limitations. First, the
increase in the frequency of the conditions observed for this report did not necessarily
result from the wildfires. Certain persons who suffered from these conditions may have
never presented at a hospital because they chose not to seek medical care or were seen by
their private physician. Second, coding practices differ slightly between hospitals and
may change over time within the same hospital.
This report illustrates that rapid surveillance of non-reportable diseases and
conditions is possible during a public health disaster. The surveillance strategy included
1) identifying key staff in local hospitals well in advance of a disaster, 2) developing
connections with these persons to ensure rapid access to critical information, and 3)
providing simple data collection instruments that minimize confusion.
References
1. Karels J. 1998 Wildland Fire Season in Review. Florida Fire Service
Today 1998;6:8-19.
2. Minshew P, Towle J. The 1998 Wildfires in Central Florida -- Volusia County's own
Armageddon. J Environ Health 1999 (in press).
The table originally included in the MMWR article did not reproduce well for inclusion in the Epi Update. If you wish to view the table, please do so at the following address: http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/00056377.htm. For those of you who would prefer a hard copy, please send your e-mail requests to natalie_tackett@doh.state.fl.us. Include your fax number and/or address. --Eds.
3. Surveillance of Morbidity during Wildfires: Lessons Learned in 1998
and Tips for 1999
Zuber D. Mulla, MSPH, Regional Epidemiologist for Central Florida
During the summer of 1998, concern about the possible adverse health effects of the
wildfires led the Volusia County Health Department and the Bureau of Epidemiology to
conduct hospital-based surveillance of 13 conditions including asthma, acute bronchitis,
and conjunctivitis (see previous article).
The 1999 wildfire season has started in Florida. If our past experience is any
indication, county health departments may be asked by politicians, physicians, and the
general public to determine if the fires are causing an increase in the frequency of
certain conditions. Since asthma, acute bronchitis, and conjunctivitis, are not reportable
to the Department of Health and county health departments (CHDs) by law, data on these
conditions must be specially requested from the local health care providers.
Last year when gearing up for this project we learned a few lessons that might be
helpful for others contemplating active surveillance for fire and smoke related morbidity
First - We found that collaborating with both the hospital infection control
practitioners (ICPs) as well as staff from the medical records department was beneficial.
The ICPs, at times, acted as liaisons between the medical records staff at their
respective hospitals and the Volusia CHD. This strategy seemed to facilitate the rapid
transfer of data.
Second - Our overall approach to data collection was to keep it simple. We chose a
series of 13 conditions that were easy for the hospital staff to identify and collect
information on. Next time, perhaps we would choose fewer. Our request did not ask for the
number of cases of a particular condition by ICD-9 code. We also found that coding
practices varied somewhat from hospital to hospital. For example, asthma is represented by
several codes. A particular hospital may never use all of these codes when coding an
asthma case. In order to avoid missing cases, we furnished the hospitals with plain
English text and avoided the used of codes.
Third We chose a particular time frame for the current fire event and the
same period for the previous year for comparison and used the same parameters for all
hospitals surveyed.
Fourth We used a simple data collection instrument and took the time to
explain it to staff involved in its completion. This time on the front end paid dividends
by promoting cooperation, avoiding delays and encouraged completion by a certain date.
Whenever possible the form was hand delivered to the hospital so staff participating
collection of the information requested had an opportunity to meet us and ask questions
they might have. If this was not possible we faxed the form and followed up with a
personal phone call. A sample table is shown below.
Frequency of Emergency Room Visits for Selected Conditions, and Percentage Change
during May 1998 and 1999, X County
| Principal Diagnosis |
1998 |
1999 |
% Change |
| Asthma |
20 |
40 |
100 |
| Acute bronchitis |
5 |
4 |
- 20 |
| Etc, etc |
|
|
|
Fifth In hindsight, we now believe it is only necessary to ask for data on
emergency room (ER) visits. Last year we also asked the hospitals to furnish the numbers
of admissions for the same 13 conditions. This no doubt delayed our data request, and,
furthermore, the number of hospital admissions did not convey much information. The
numbers were small and the overall change between 1997 and 1998 was small.
Sixth We also learned to recognize and appreciate that coding practices may
vary within one hospital over time. For instance, a large increase or decrease between
1998 and 1999 for a particular condition for a particular hospital may mean that in 1998,
ER staff coded ER visits, but this year medical records staff coded ER visits.
Finally One must always keep in mind that these are surveillance data
nothing more. Any increase in the frequency of the conditions over time is not necessarily
due to the fires. Also, certain persons who suffered from these conditions may have never
presented at a hospital because they chose not to seek medical care or were seen by their
private physician.
Those with any additional questions regarding the institution of an active surveillance
at hospital ERs in their area may direct them to Mr. at hospital ERs in their
area may direct them to Mr. Zuber Mulla at (407) 623-1212 or SC 334-1212 ext. 178. Mr.
Mulla is also on the departmental Intranet via cc-mail.
As a matter of interest, the Florida Department of Community Affairs has compiled 1998
wildfire statistics (number of acres burned, value of destroyed property, etc.) They can
be contacted at (850) 413-9969 or Suncom 293-9969. Current health alerts may be found at
the Website of the Department of Health (www.doh.state.fl.us). This site also has
information on emergency operations
4. Epidemiology Grand Rounds for April
John F. Werth, M.A. Bureau Education Coordinator
Bureau of Epidemiology Grand Rounds - Session 2
April 27, 1999 - Audioconference
11:00 AM 12:00 PM EST
On April 27, the Epidemiology Grand Rounds will feature Dr. Russell E. Mardon, Senior
Management Analyst, with the Florida Department of Healths Bureau of Environmental
Epidemiology. Dr. Mardon will present "Cancer Risks and Environmental Exposures
in St. Lucie County Florida: Report to the Community." This presentation will
describe the recent investigation into the association between environmental
chemicals and childhood cancer in St. Lucie County and will include
epidemiologic methods and results, and strategies for communicating with the
public.
Bureau of Epidemiology Grand Rounds
The Epidemiology Grand Rounds, a monthly, one-hour audioconference
conducted by the Bureau of Epidemiology, will focus on issues of epidemiologic interest to
Florida public health providers, including; county health department directors and
administrators, nursing directors and nurse epidemiologists, laboratorians, and other
interested parties. Each session will feature a formal PowerPoint presentation (materials
will be distributed before the call), followed by an opportunity for audience interaction.
Presenters will include representatives of the State Department of Health, county health
departments, schools of public health and other experts in epidemiology and associated
specialties. Richard Hopkins, M.D., MSPH, Floridas State Epidemiologist, will
coordinate the presentations. Those interested in participating, as a speaker, should
contact Dr. Hopkins at (850) 488-2905, SUNCOM 278-2905 or E-mail: [Richard_Hopkins@doh.state.fl.us]. Assistance with PowerPoint can be provided.
1999 Audioconference Dates:
April 27 June 29 August 31 October 26
May 25 July 27 September 28 November 30
December 28
Audioconference Dial-in Tips:
Please consider the following tips for making the Grand Rounds more useful and
enjoyable:
- Never
call in using a cellular telephone or cordless headset.
- Leave your telephone "mute button" on during the call (except
when asking questions).
- Do not put your phone on "hold" and leave the call, this can subject the
entire audience to listen to music or your hold message.
- Dial-in on time.
5. Hepatitis C Guidelines for County Health Directors and
Administrators
Steven Wiersma, MD, MPH, Deputy State Epidemiologist
The Bureau of Epidemiology continues to receive a large number of requests for
information from county health departments in areas that are specifically covered in a DOH
interoffice memorandum. We hope that by publishing that memorandum in the Epi Update, more
CHD staff can review the policies and recommendations described and discuss them with
others.
Thank You. SW.
INTEROFFICE MEMORANDUM
DATE: February 18,1999
TO: County Health Directors/Administrators
THROUGH: Richard C. Hunter,.Ph.D.
Deputy State Health Officer
FROM: Steven Wiersma, M.D., M.P.H.
Deputy State Epidemiologist
SUBJECT: Hepatitis CDepartment of Health Guidelines for Prevention and
Control
__________________________________________________________________________
Hepatitis C reports are increasing dramatically as new testing technology gains
acceptance. The hepatitis C situation is often referred to as "the silent
epidemic" because so few of those who carry the virus are aware of their infection.
It is believed that as many as 4 million Americans are infected with hepatitis C, four
times the number of HIV infections nationally. This translates to more than 200,000
hepatitis C infections in Florida.
Hepatitis C infections cause significant human suffering and death. Hepatitis C is the
most common blood-borne infection, the most common cause of chronic hepatitis and the most
common cause of liver transplants. Deaths from chronic hepatitis C may soon overtake the
number of AIDS-related deaths. In addition to significant losses of productive life years,
medical treatment costs are estimated to be hundreds of millions of dollars annually in
the United states.
Prevention efforts for hepatitis C focus on primary prevention, to prevent new cases,
and secondary prevention, to reduce the burden of hepatitis C virus-related disease in
those already infected. Attention to hepatitis C virus prevention has been made possible
by a better knowledge of hepatitis C virus epidemiology as well as new treatments for
those chronically infected with the hepatitis C virus. As with HIV treatments, these
hepatitis treatments are expensive but are continually improving.
County Health Departments can expect a steady increase in requests for information
about the hepatitis C virus or HCV, requests for testing, explanations of test results and
requests for referral to a source of care for biopsy and treatment. This increased demand
for services will accelerate as various national and statewide bodies begin planned media
campaigns.
There are currently no additional state funds available to support these activities,
although proposals for funding may be considered during the current legislative session.
At this point, the Department of Health is still only maintaining surveillance for
acute infection with the hepatitis A, B and C viruses at the state level, not for newly
detected persons with chronic infection, even if symptoms have developed only recently. If
additional funding is appropriated, we intend to add surveillance for newly detected
chronic infection as well, including both symptomatic and asymptomatic chronic infection.
This will involve the development of a hepatitis registry.
The state laboratory is offering the basic screening test for hepatitis C enzyme
immunoassay or EIA. The state lab will charge county health departments for enzyme
immunoassay for anti-hepatitis C virus tests done in support of screening activities. The
confirmatory tests, recombinant immunoblot assayRIBAÔ or
reverse transcriptase polymerase chain reactionRT-PCR and the follow-up test,
alanine aminotransferase or ALT,will have to be ordered from a commercial laboratory.
The following list of recommendations is offered to prepare for anticipated inquiries
about the hepatitis C virus:
- County health departments should assemble a list of local physicians who will take
referrals for hepatitis C screening and for follow-up care after a positive test.
- If county health departments choose to offer screening:
- Screening should be offered in accordance with published Centers for Disease Control and
Prevention recommendations. (Recommendations for Prevention and Control of Hepatitis C
Virus (HCV) Infection and HCV-Related Chronic Disease, MMWR,
47(RR-19), October 16, 1998. Available from the Bureau of Epidemiology at
http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/00055154.htm)
- Adequate pre- and post-test counseling should be provided to those screened using the
model of HIV-test counseling.
- County Health Departments should have a plan for medical referral of screened persons
for follow-up care, regardless of health insurance status.
Because misinformation on hepatitis C virus is widespread, use care when recommending
sources of information to clients. The Bureau of Epidemiology can provide current public
health recommendations and sources for accurate information.
6. Influenza Summary Update Week 14 (week ending April 10 1999)
Carina Blackmore, MS Vet Med., PhD., Regional Epidemiologist, NE
Florida
National: Influenza morbidity peaked during February and has been
declining during March and early April. During week 14, five states (Alaska, Arizona,
Maryland, Louisiana and Tenneessee) reported either regional or widespread activity,
compared to 10 states the previous week. The WHO laboratories reported that 15% (11,998 of
77,649) of the specimens tested since October 4 have been positive for influenza. Seventy
seven percent (9,217) of these were influenza A. Among the type A viruses, 25% have been
subtyped. Subtype A(H3N2) has predominated (99% of 2,322)). Twenty isolates have been
subtyped as A(H1N1) So far this season, influenza A have been the most common subtype in
the U.S. overall and in all of the nine regions; however the percentage of influenza type
a viruses have varied by region, ranging from 61% in the East North Central region to 91%
in the New England region. Of the total patient visits to sentinel physicians, 1% were due
to ILI (influenza-like-illness) in the U.S. overall. The percentage of patient visits was
within baseline values of 0%-3% nationally and in all nine regions. The percentage of
pneumonia and influenza deaths reported from the 122 cities during Week 14 was 8.3 %,
above the epidemic threshold of 7.3%. The percentage of deaths from pneumonia and
influenza continue to decline. However the percentage of pneumonia and influenza deaths
remained above the epidemic threshold for the eleventh consecutive week.
Florida: During week 14 (4-10 April 1999) there were 6 laboratory-confirmed
isolates of influenza reported: Influenza A was reported from Orange, Palm Beach and
Sarasota (AH3N2) counties. Influenza B was reported from Broward and Orange counties.
Since September 23 and to date, there have been 222 isolates reported; 67 (30%) of these
were type B, and 155 type A. Of the influenza A isolates 65 (30 %) were typed; 59 (91%)
were type A(H3N2), 6 (9%) were type A(H1N1). Isolates have been reported from: Alachua
(1), Brevard (5), Broward (24), Dade (5), Desoto (1), Duval (13), Hillsborough (47),
Indian River (5), Leon (19), Martin (2) Okaloosa (2), Orange (21), Osceola (1), Palm Beach
(17), Pinellas (12), Polk (3), Sarasota (20), Seminole (2), St. Johns (1) and
Volusia (2) counties.
Of the total patient visits to sentinel physicians during Week 14,1 % were due to ILI.
This is within the baseline levels of 0-3%. Since October 4 the percentage has ranged
between 1 and 4%. Influenza-like illness has been reported from health care providers in
20 of the 21 Florida counties in the sentinel physician surveillance network.
7. Florida Past: Public Health Pioneers, Polio Vaccines and Prevention
Campaigns
William J. Bigler, PhD.
Poliomyelitis, despite having roots in antiquity, was not generally recognized in the
United States as a paralytic disease with epidemic potential until about the turn of the
century. Once major clinical and epidemiologic features and modes of transmission were
defined, it was still many years before experimental work on antigenic types of viruses,
pathogenesis and immunity set the stage for control by means of mass immunization. The war
babies and early "boomers" witnessed the miraculous transition from a childhood
haunted with fear of contagion and paralysis to recognition that their own children would
be protected from the ravages of this disease. What most of us are not aware of is how
this was accomplished so quickly. One of the untold stories is the leadership role played
by Floridas State Board of Health (SBH) and county health departments (CHDs) and
their many allies in conducting field trials on experimental vaccines prior to the
initiation of mass immunization campaigns.
The epidemic potential of this major crippling disease generally began to be recognized
throughout the nation in the late 1930s. During WWII (1940-45) Florida was averaging
about 100 reported cases per year. However, by the end of 1946, over 500 cases had been
reported. The following year only 111 cases were reported in the state, but the case count
continued to increase during the late 1940s and early 1950s. Then in late
1953, another statewide outbreak began and 1,777 cases were reported in 1954. The SBH and
CHDs in collaboration with the National Office of Defense Mobilization, the National
Foundation of Infantile Paralysis and the American Red Cross, vaccinated thousands with
Gamma Globulin. At the same time the new Salk injectible vaccine was being tested in 2nd
grade students in Palm Beach and Broward Counties.
The availability of free Salk vaccine in April 1955 provided the first real opportunity
for the SBH and CHDs to conduct a major prevention campaign against Polio. That year an
estimated 270,648 children (0-15 years old) or one fourth of the estimated 1,098,319
children in that age group residing in Florida received one or more vaccine injections.
The National Polio Surveillance Center data collected in Florida confirmed the safety and
efficacy of the vaccine. The number of cases reported decreased during the late
1950s and in 1959 less than 200 cases were reported.
The introduction of Sabin Oral Polio Vaccine early in 1960 prompted the Dade County
Department of Public Health, Dade County Medical Association and the University of Miami
School of Medicine to collaborate on a large scale vaccination campaign. The oral
vaccination of 425,000 Dade County residents proved the vaccines to be acceptable to the
public and generally effective, although the strains tested had to be administered singly
and in succession.
When an opportunity arose to test a trivalent oral polio vaccine administered in a
two-dose series early in 1962, the SBH and Lederle Laboratories supported efforts by the
Hillsborough CHD and Hillsborough County Medical Association to conduct a field trial of
the new vaccine. A detailed description of the project entitled "Hillsborough County
Oral Polio Vaccine Program", edited by John S. Neill and James O. Bond was published
in 1964 as Florida State Board of Health Monograph Number 6. Excerpts that highlight key
activities and findings follow.
"Health Departments in Florida participated in the earliest trials of the
Salk Vaccine. There was even more interest in the Sabin oral vaccine. The new vaccine
appeared to be a preparation, which would be readily accepted by the public
The
effort is commendable because of the
cooperation between these organizations (the CHD
and County Medical Association) and the various voluntary agencies, industrial groups, and
the citizens of Hillsborough County
Particular attention was directed to population
groups considered "hard to reach."
(and) a high percentage of
these
took the vaccine
This monograph gives the findings of that
productive research and a successful
program. Of broader importance, it may be a move
toward the eradication of poliomyelitis from Hillsborough County, from Florida, from the
United States, and hopefully, eventually from the world
" --Albert V. Hardy,
MD, DrPH
"This monograph summarizes the methods and results of the first large United
States field trial of a trivalent oral polio vaccine prepared from the Sabin Strains of
attenuated polio virus. (387,000 doses administered during a three-month period). The
objectives
included (1) an evaluation of the immunogenicity of the vaccine in
susceptible children; (2) measurement of the ability of the vaccine to reduce the
transmission of polio
in the community, and (3) the elimination of clinical paralytic
poliomyelitis as a public health problem in Hillsborough County. The program
also
measure(d)
those factors that were significant in either personal or
community acceptance of the program.
The oral trivalent vaccine was found effective by
clinical, virological and
serologic measurements. In the serologic study, 422 children (who)
had no
demonstrable antibodies
against all three types of polio virus (had) 90.4 per cent
conversion to Type I, 99.7 per cent to Type II, and 98.0 per cent to Type III
Oral polio vaccine virus
circulating in the community was recovered
from
sewage and rectal swabs (from healthy preschool
children) during the period
of administration of vaccine.
(afterward) there was a gradual decline in the
percentage of recoveries. Sewage specimens dropped from 39
to six percent (and)
rectal swab(s) dropped from 16 per cent
to zero
Careful
surveillance for (CNS) viral infections
initiated in
October
196I
(and) continued throughout the field trial and for 18 months
thereafter
. (revealed) four cases of clinical paralytic disease
(only one), an
18 month old ,
(had) Type I poliovirus.. (in) the stools.. (with)
clinical
asymetric flaccid paralysis. This child had received two doses of the
trivalent vaccine in February and April of 1962, however, there was no evidence of Polio
CF antibodies in either the acute or convalescent sera
During the field trial it became readily apparent that the Hillsborough County
community is a heterogenous social group, and public health programs must be tailored to
fit the individual needs of each subculture
The program became a truly
multidisciplinary effort, in which nurses, sanitarians, clerks, psychologists, physicians,
social workers and the entire (CHD) staff joined forces to mobilize
the
community
The necessity of maintaining protection in the community by immunization
of all newborns or new arrivals
with emphasis on education and an appreciation of the
importance of immunization (requires).. a follow-up program (that) has been
organized
and is being effectively carried out." --James O. Bond MD, MPH and
John S. Neill, MD, MPH
8. Weekly Disease Table - Week 15
County-Confirmed Cases, Sorted Alphabetically by Disease
NR represents years that the disease lacked status as a reportable condition
DISEASE |
1996 TO DATE |
1997 TO DATE |
1998 TO DATE |
3 YEAR AVERAGE
TO DATE |
1998 TOTAL CASES |
1999 TO DATE |
| Amebiasis |
18 |
9 |
9 |
12 |
91 |
8 |
| Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
| Botulism |
0 |
0 |
0 |
0 |
0 |
0 |
| Brucellosis |
3 |
0 |
1 |
1.3 |
3 |
0 |
| Campylobacteriosis |
246 |
201 |
142 |
196.3 |
977 |
195 |
| Ciguatera |
7 |
2 |
0 |
3 |
7 |
0 |
| Cryptosporidiosis |
27 |
18 |
26 |
23.7 |
203 |
20 |
| Cyclosporiasis |
0 |
0 |
2 |
0.7 |
7 |
0 |
| Dengue |
0 |
0 |
1 |
0.3 |
7 |
2 |
| Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
| E. coli O157:H7 |
5 |
13 |
3 |
7 |
56 |
9 |
| E. coli, other (known serotype) |
2 |
2 |
2 |
2 |
12 |
7 |
| Ehrlichiosis, Human |
0 |
0 |
0 |
0 |
1 |
0 |
| Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
| Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
1 |
0 |
| Encephalitis, other (known organism) |
1 |
5 |
3 |
3 |
7 |
2 |
| Encephalitis, post-infectious* |
4 |
3 |
0 |
2.3 |
21 |
1 |
| Giardiasis (acute) |
362 |
324 |
262 |
316 |
1634 |
195 |
| Haemophilus influenzae*, invasive |
3 |
5 |
12 |
6.7 |
42 |
14 |
| Hansens Disease (Leprosy) |
0 |
0 |
2 |
0.7 |
4 |
0 |
| Hantavirus Infection |
0 |
0 |
0 |
0 |
0 |
0 |
| Hemolytic Uremic Syndrome |
0 |
2 |
0 |
0.7 |
12 |
1 |
| Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
| Hepatitis A |
88 |
121 |
150 |
119.7 |
547 |
157 |
| Hepatitis B |
92 |
84 |
81 |
85.7 |
504 |
86 |
| Hepatitis Non-A, Non-B |
17 |
18 |
19 |
18 |
101 |
4 |
| Hepatitis, unspecified |
1 |
0 |
0 |
0.3 |
25 |
2 |
| Histoplasmosis |
2 |
0 |
2 |
1.3 |
17 |
0 |
| Kawasaki |
7 |
6 |
13 |
8.7 |
53 |
0 |
| Lead Poisoning |
380 |
318 |
406 |
368 |
1850 |
122 |
| Legionellosis |
5 |
5 |
13 |
7.7 |
47 |
6 |
| Leptospirosis |
0 |
0 |
0 |
0 |
2 |
0 |
| Lyme Disease |
2 |
4 |
5 |
3.7 |
73 |
3 |
| Malaria |
13 |
18 |
16 |
15.7 |
96 |
20 |
| Measles |
1 |
0 |
1 |
0.7 |
2 |
1 |
| Meningococcal Disease (N. meningitidis) |
76 |
59 |
45 |
60 |
132 |
33 |
| Meningitis, Group B Streptococci |
7 |
3 |
2 |
4 |
21 |
5 |
| Meningitis, Haemophilus influenzae |
1 |
3 |
3 |
2.3 |
11 |
4 |
| Meningitis, Streptococcus pneumoniae |
36 |
28 |
37 |
33.7 |
94 |
38 |
| Meningitis, Listeria monocytogenes |
2 |
0 |
2 |
1.3 |
14 |
6 |
| Meningitis, other bacterial (including
unspecified) |
28 |
13 |
12 |
17.7 |
80 |
22 |
| Mercury Poisoning |
1 |
0 |
0 |
0.3 |
4 |
1 |
| Mumps |
2 |
7 |
2 |
3.7 |
11 |
1 |
| Paralytic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
| Pertussis |
13 |
22 |
11 |
15.3 |
39 |
7 |
| Pesticide Poisoning |
0 |
0 |
1 |
0.3 |
1 |
1 |
| Plague |
0 |
0 |
0 |
0 |
0 |
0 |
| Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
| Psittacosis |
0 |
0 |
0 |
0 |
2 |
0 |
| Rabies, Animal |
62 |
82 |
67 |
70.3 |
215 |
47 |
| Reye Syndrome |
0 |
0 |
1 |
0.3 |
1 |
0 |
| Rocky Mountain Spotted Fever |
0 |
1 |
1 |
0.7 |
3 |
1 |
| Rubella, including congenital |
10 |
0 |
1 |
3.7 |
4 |
0 |
| Salmonellosis |
414 |
339 |
353 |
368.7 |
3040 |
381 |
| Shigellosis |
185 |
262 |
325 |
257.3 |
2349 |
348 |
| Streptococcal Disease, invasive Group A |
0 |
12 |
13 |
8.3 |
55 |
19 |
| Streptococcus pneumoniae, Drug
Resistant |
0 |
63 |
159 |
74 |
517 |
199 |
| Tetanus |
0 |
0 |
1 |
0.3 |
3 |
1 |
| Toxic Shock Syndrome |
0 |
0 |
3 |
1 |
4 |
3 |
| Toxoplasmosis |
4 |
1 |
4 |
3 |
15 |
3 |
| Typhoid Fever |
6 |
3 |
6 |
5 |
16 |
16 |
| Typhus (Louse & Murine) |
0 |
0 |
0 |
0 |
1 |
0 |
| Vibrio cholerae (serogrp O1) |
0 |
0 |
0 |
0 |
0 |
0 |
| Vibrio cholerae (serogrp Non-O1) |
1 |
3 |
1 |
1.7 |
12 |
2 |
| Vibrio vulnificus |
0 |
1 |
1 |
0.7 |
35 |
2 |
| Vibrio other (including unspecified) |
3 |
7 |
3 |
4.3 |
75 |
7 |
| Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|